All-Cause Mortality

All-cause mortality, the rate of death from any cause within a defined population, is increasingly recognized as a fundamental biomarker for longevity research. It serves as a comprehensive indicator of overall health and resilience, reflecting the cumulative impact of various biological and environmental factors on lifespan. A lower all-cause mortality rate generally suggests improved healthspan and a greater likelihood of living longer.

The available evidence suggests a potential link between interventions and reduced all-cause mortality. One human study indicated a decrease in the hazard ratio for all-cause mortality, with an effect size of 0.75. A hazard ratio below 1 indicates a lower risk of death in the intervention group compared to the control group. This finding suggests that the intervention studied may have a protective effect against mortality.

While promising, it's important to interpret these findings with caution. The current evidence base is limited, with only one human study identified. The absence of randomized controlled trials (RCTs) and meta-analyses further restricts the strength of the conclusions that can be drawn. More research, particularly well-designed human studies with larger sample sizes and longer follow-up periods, is needed to confirm these initial observations and to fully understand the potential of interventions to impact all-cause mortality.